Pell Bio-Med Technology Balance Sheet

Financials in millions TWD. Fiscal year is January - December.

Millions TWD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '25 Mar 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Equivalents	558.47	427.37	167.68	172.4	115.78
Short-Term Investments	449.75	679.75	938.15	536	-
Trading Asset Securities	17.7	29.06	-	-	-
Cash & Short-Term Investments	1,026	1,136	1,106	708.4	115.78
Cash Growth	-24.20%	2.74%	56.10%	511.84%	-
Accounts Receivable	3.17	3.75	7.61	6.05	4.5
Other Receivables	2.57	0.56	0.33	0.36	6.12
Receivables	5.73	4.31	7.94	6.41	10.62
Inventory	6.24	6.18	3.76	4.58	4.24
Prepaid Expenses	8.87	9.22	8.86	5.84	1.1
Other Current Assets	-	1.84	0.65	0.16	0.08
Total Current Assets	1,047	1,158	1,127	725.39	131.82
Property, Plant & Equipment	485.13	386.45	260.92	298.97	249.74
Long-Term Investments	0.37	0.37	0.37	0.26	0.26
Other Intangible Assets	1.86	1.89	2.4	2.71	1.47
Other Long-Term Assets	141.88	198.39	27.44	17.07	10.61
Total Assets	1,676	1,745	1,418	1,044	393.89
Accounts Payable	3.38	4.49	6.99	5.72	8.61
Accrued Expenses	81.82	64.12	39.74	14.58	19.19
Short-Term Debt	200	200	-	5	-
Current Portion of Leases	27.66	27.55	25.09	25.07	10.76
Current Unearned Revenue	-	-	-	-	0.75
Other Current Liabilities	11.69	25.19	17.47	6.86	4.87
Total Current Liabilities	324.56	321.35	89.3	57.24	44.18
Long-Term Leases	130.31	137.27	147.47	172.56	124.84
Total Liabilities	454.87	458.62	236.77	229.79	169.02
Common Stock	581.19	578.43	539.43	443.65	333.76
Additional Paid-In Capital	1,813	1,804	1,449	774.25	77.38
Retained Earnings	-1,283	-1,207	-817.85	-419.09	-188.96
Treasury Stock	-0.8	-0.8	-0.8	-	-
Comprehensive Income & Other	5.47	5.52	-	2.13	2.69
Total Common Equity	1,116	1,180	1,170	800.94	224.86
Minority Interest	104.8	106.29	11.18	13.67	0.01
Shareholders' Equity	1,221	1,286	1,181	814.6	224.87
Total Liabilities & Equity	1,676	1,745	1,418	1,044	393.89
Total Debt	357.97	364.82	172.56	202.63	135.6
Net Cash (Debt)	667.95	771.36	933.27	505.77	-19.82
Net Cash Growth	-43.72%	-17.35%	84.52%	-	-
Net Cash Per Share	11.53	13.52	20.17	12.89	-0.60
Filing Date Shares Outstanding	58.08	57.8	53.9	44.36	33.28
Total Common Shares Outstanding	58.08	57.8	53.9	44.36	33.28
Working Capital	722.21	836.38	1,038	668.15	87.64
Book Value Per Share	19.22	20.41	21.71	18.05	6.76
Tangible Book Value	1,114	1,178	1,168	798.22	223.39
Tangible Book Value Per Share	19.19	20.38	21.67	17.99	6.71
Machinery	95.9	95.05	90.37	81.84	75.31
Construction In Progress	257.91	148.34	-	-	-
Leasehold Improvements	86.72	86.72	86.72	86.18	86

Source: S&P Global Market Intelligence. Standard template. Financial Sources.